BioXcel Therapeutics, Inc. (BTAI) Discussion of Managing Acute Agitation in Schizophrenia and Bipolar Disorders at Home Transcript
Source: SeekingAlpha
2025-12-11 06:42:48 ET
BioXcel Therapeutics, Inc. (BTAI) Discussion of Managing Acute Agitation in Schizophrenia and Bipolar Disorders at Home December 8, 2025 10:02 AM EST...
Read the full article on Seeking Alpha
For further details see:
BioXcel Therapeutics, Inc. (BTAI) Discussion of Managing Acute Agitation in Schizophrenia and Bipolar Disorders at Home Transcript
BioXcel Therapeutics Inc.
NASDAQ: BTAI
BTAI Trading
-2.19% G/L:
$1.57 Last:
249,111 Volume:
$1.57 Open:
BTAI Latest News
March 11, 2026 04:20:00 pm
BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering
March 10, 2026 02:36:00 pm
BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering
BTAI Stock Data
$36,631,397
21,060,320
0.54%
17
N/A
Biotechnology & Life Sciences
Healthcare
US
New Haven
